Code,Code_Description,DiseaseGroup,CodeType
B171,Allotransplantation of thymus gland,Transplant,OPCS-4
B178,Other specified transplantation of thymus gland,Transplant,OPCS-4
B179,Unspecified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y012",Other specified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y013",Other specified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y014",Other specified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y015",Other specified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y016",Other specified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y018",Other specified transplantation of thymus gland,Transplant,OPCS-4
"B208,Y019",Unspecified transplantation of thymus gland,Transplant,OPCS-4
B211,HIV disease resulting in Burkitt lymphoma,Cancer undergoing active chemo/radiotherapy,ICD-10
B238,HIV disease resulting in other specified conditions,Cancer undergoing active chemo/radiotherapy,ICD-10
C000,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C001,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C002,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C003,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C004,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C005,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C006,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C008,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C009,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C01,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C020,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C021,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C022,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C023,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C024,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C028,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C029,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C030,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C031,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C039,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C040,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C041,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C048,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C049,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C050,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C051,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C052,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C058,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C059,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C060,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C061,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C062,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C068,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C069,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C07,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C080,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C081,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C088,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C089,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C090,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C091,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C098,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C099,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C100,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C101,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C102,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C103,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C104,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C108,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C109,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C110,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C111,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C112,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C113,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C118,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C119,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C12,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C130,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C131,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C132,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C138,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C139,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C140,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C142,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C148,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C150,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C151,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C152,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C153,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C154,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C155,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C158,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C159,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C160,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C161,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C162,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C163,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C164,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C165,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C166,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C168,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C169,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C170,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C171,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C172,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C173,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C178,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C179,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C180,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C181,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C182,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C183,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C184,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C185,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C186,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C187,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C188,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C189,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C19,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C20,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C210,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C211,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C212,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C218,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C220,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C221,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C222,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C223,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C224,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C227,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C229,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C23,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C240,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C241,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C248,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C249,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C250,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C251,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C252,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C253,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C254,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C257,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C258,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C259,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C260,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C261,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C268,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C269,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C300,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C301,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C310,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C311,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C312,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C313,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C318,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C319,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C320,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C321,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C322,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C323,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C328,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C329,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C33,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C340,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C341,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C342,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C343,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C348,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C349,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C37,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C380,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C381,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C382,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C383,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C384,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C388,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C390,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C398,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C399,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C400,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C401,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C402,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C403,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C408,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C409,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C4101,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-101
C4102,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-102
C411,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C412,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C413,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C414,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C418,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C419,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C430,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C431,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C432,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C433,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C434,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C435,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C436,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C437,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C438,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C439,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C440,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C441,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C442,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C443,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C444,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C445,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C446,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C447,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C448,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C449,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C450,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C451,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C452,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C457,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C459,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C460,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C461,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C462,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C463,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C467,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C468,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C469,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C470,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C471,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C472,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C473,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C474,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C475,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C476,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C478,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C479,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C480,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C481,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C482,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C488,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C490,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C491,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C492,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C493,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C494,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C495,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C496,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C498,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C499,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C500,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C501,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C502,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C503,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C504,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C505,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C506,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C508,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C509,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C510,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C511,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C512,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C518,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C519,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C52,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C530,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C531,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C538,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C539,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C540,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C541,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C542,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C543,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C548,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C549,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C55,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C56,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C570,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C571,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C572,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C573,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C574,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C577,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C578,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C579,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C58,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C600,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C601,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C602,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C608,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C609,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C61,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C620,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C621,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C629,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C630,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C631,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C632,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C637,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C638,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C639,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C64,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C65,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C66,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C670,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C671,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C672,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C673,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C674,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C675,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C676,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C677,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C678,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C679,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C680,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C681,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C688,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C689,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C690,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C691,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C692,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C693,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C694,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C695,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C696,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C698,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C699,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C700,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C701,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C709,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C710,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C711,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C712,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C713,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C714,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C715,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C716,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C717,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C718,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C719,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C720,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C721,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C722,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C723,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C724,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C725,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C728,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C729,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C73,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C740,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C741,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C749,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C750,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C751,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C752,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C753,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C754,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C755,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C758,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C759,"Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue",Cancer undergoing active chemo/radiotherapy,ICD-10
C437,Transplantation of conjunctiva,Transplant,OPCS-4
"C438,Y012",Transplantation of conjunctiva,Transplant,OPCS-4
"C438,Y013",Transplantation of conjunctiva,Transplant,OPCS-4
C467,Transplant of corneal lumbal cells,Transplant,OPCS-4
C760,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C761,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C762,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C763,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C764,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C765,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C767,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C768,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C770,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C771,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C772,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C773,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C774,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C775,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C778,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C779,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C780,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C781,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C782,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C783,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C784,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C785,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C786,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C787,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C788,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C790,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C791,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C792,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C793,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C794,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C795,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C796,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C797,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C7981,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-101
C7982,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-102
C7988,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-109
C80,"Malignant neoplasms of ill-defined, secondary and unspecified sites",Cancer undergoing active chemo/radiotherapy,ICD-10
C780,Secondary neoplasm lung,Cancer undergoing active chemo/radiotherapy,ICD-10
C810,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C811,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C812,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C813,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C817,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C819,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C820,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C821,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C822,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C827,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C829,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C830,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C831,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C832,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C833,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C834,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C835,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C836,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C837,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C838,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C839,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C840,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C841,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C842,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C843,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C844,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C845,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C850,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C851,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C857,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C859,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8800,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8801,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8810,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8811,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8820,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8821,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8830,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8831,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8870,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8871,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8890,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C8891,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9000,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9001,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9010,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9011,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9020,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9021,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9100,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9101,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9110,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9111,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9120,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9121,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9130,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9131,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9140,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9141,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9150,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9151,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9170,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9171,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9190,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9191,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9200,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9201,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9210,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9211,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9220,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9221,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9230,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9231,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9240,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9241,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9250,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9251,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9270,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9271,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9290,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9291,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9300,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9301,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9310,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9311,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9320,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9321,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9370,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9371,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9390,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9391,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9400,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9401,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9410,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9411,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9420,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9421,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9430,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9431,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9440,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9441,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9450,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9451,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9470,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9471,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9500,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9501,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9510,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9511,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9520,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9521,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9570,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9571,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9590,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C9591,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C960,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C961,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C962,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C963,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C967,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C969,"Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
C965,Multifocal and unisystemic Langerhans-cell histiocytosis,Cancer undergoing active chemo/radiotherapy,ICD-10
D097,Carcinoma in situ of other specified sites,Cancer undergoing active chemo/radiotherapy,ICD-10
D374,Neoplasm of uncertain or unknown behaviour: Colon,Cancer undergoing active chemo/radiotherapy,ICD-10
D377,Neoplasm of uncertain or unknown behaviour: Other digestive organs,Cancer undergoing active chemo/radiotherapy,ICD-10
D470,Histiocytic and mast cell tumours of uncertain and unknown behaviour,Haematological Cancers,ICD-10
D475,Chronic eosinophilic leukaemia [hypereosinophilic syndrome],Haematological Cancers,ICD-10
D477,"Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",Haematological Cancers,ICD-10
D479,"Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified",Haematological Cancers,ICD-10
D570,Sickle-cell anaemia with crisis,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D571,Sickle-cell anaemia without crisis,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D572,Double heterozygous sickling disorders,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D595,Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli],Haematological Cancers,ICD-10
D70,Agranulocytosis,Cancer undergoing active chemo/radiotherapy,ICD-10
D71X,Functional disorders of polymorphonuclear neutrophils,Haematological Cancers,ICD-10
D730,Hyposplenism,Haematological Cancers,ICD-10
D760,"Langerhans' cell histiocytosis, not elsewhere classified",Haematological Cancers,ICD-10
D761,Haemophagocytic lymphohistiocytosis,Haematological Cancers,ICD-10
D800,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D801,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D802,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D803,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D804,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D805,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D806,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D807,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D808,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D809,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D810,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D811,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D812,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D813,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D814,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D815,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D816,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D817,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D818,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D819,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D820,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D821,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D822,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D823,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D824,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D828,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D829,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D830,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D831,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D832,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D838,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D839,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D840,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D841,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D848,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D849,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D860,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D861,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D862,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D863,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D868,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D869,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D890,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D891,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D892,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D898,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
D899,Certain disorders involving the immune mechanism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E531,Double lung transplant,Transplant,OPCS-4
E532,Single lung transplant,Transplant,OPCS-4
E533,Single lobe lung transplant,Transplant,OPCS-4
E538,Other specified transplantation of lung,Transplant,OPCS-4
E539,Unspecified transplantation of lung,Transplant,OPCS-4
E703,Albinism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E710,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E711,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E712,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E713,Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E722,Disorders of urea cycle metabolism,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E740,Glycogen storage disease,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E752,Other sphingolipidosis ,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E760,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E761,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E762,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E763,mucopolysaccharidoses,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E771,Defects in glycoprotein degradation,"Rare genetic, metabolic and autoimmune diseases",ICD-10
E840,Cystic fibrosis,Respiratory,ICD-10
E841,Cystic fibrosis,Respiratory,ICD-10
E848,Cystic fibrosis,Respiratory,ICD-10
E849,Cystic fibrosis,Respiratory,ICD-10
G10X,Huntington disease,"Rare genetic, metabolic and autoimmune diseases",ICD-10
G113,Cerebellar ataxia with defective DNA repair,"Rare genetic, metabolic and autoimmune diseases",ICD-10
G261,Allotransplantation of stomach,Transplant,OPCS-4
G268,Other specified transplantation of stomach,Transplant,OPCS-4
G269,Unspecified transplantation of stomach,Transplant,OPCS-4
"G388,Y012",Allotransplantation of stomach,Transplant,OPCS-4
"G388,Y013",Other specified transplantation of stomach,Transplant,OPCS-4
"G388,Y014",Allotransplantation of stomach,Transplant,OPCS-4
"G388,Y015",Allotransplantation of stomach,Transplant,OPCS-4
"G388,Y016",Allotransplantation of stomach,Transplant,OPCS-4
"G388,Y018",Other specified transplantation of stomach,Transplant,OPCS-4
"G388,Y019",Unspecified transplantation of stomach,Transplant,OPCS-4
G681,Allotransplantation of ileum,Transplant,OPCS-4
G688,Other specified transplantation of ileum,Transplant,OPCS-4
G689,Unspecified transplantation of ileum,Transplant,OPCS-4
G712,Congenital myopathies,"Rare genetic, metabolic and autoimmune diseases",ICD-10
"G788,Y012",Allotransplantation of ileum,Transplant,OPCS-4
"G788,Y018",Other specified transplantation of ileum,Transplant,OPCS-4
"G789,Y019",Unspecified transplantation of ileum,Transplant,OPCS-4
I270,Primary pulmonary hypertension,"Rare genetic, metabolic and autoimmune diseases",ICD-10
I712,"Thoracic aortic aneurysm, without mention of rupture",Congenital Heart,ICD-10
J011,Orthotopic transplantation of liver NEC,Transplant,OPCS-4
J012,Heterotopic transplantation of liver,Transplant,OPCS-4
J013,Replacement of previous liver transplant,Transplant,OPCS-4
J014,Transplantation of liver cells,Transplant,OPCS-4
J015,Orthotopic transplantation of whole liver,Transplant,OPCS-4
J018,Other specified transplantation of liver,Transplant,OPCS-4
J019,Unspecified transplantation of liver,Transplant,OPCS-4
J410,Simple and mucopurulent chronic bronchitis,Respiratory,ICD-10
J411,Simple and mucopurulent chronic bronchitis,Respiratory,ICD-10
J418,Simple and mucopurulent chronic bronchitis,Respiratory,ICD-10
J42,Unspecified chronic bronchitis,Respiratory,ICD-10
J440,Other chronic obstructive pulmonary disease,Respiratory,ICD-10
J441,Other chronic obstructive pulmonary disease,Respiratory,ICD-10
J448,Other chronic obstructive pulmonary disease,Respiratory,ICD-10
J449,Other chronic obstructive pulmonary disease,Respiratory,ICD-10
J46X,Status asthmaticus,Respiratory,ICD-10
J47,Bronchiectasis,Respiratory,ICD-10
J61,Pneumoconiosis due to asbestos and other mineral fibres,Respiratory,ICD-10
J620,Pneumoconiosis due to talc dust,Respiratory,ICD-10
J630,Aluminosis (of lung),Respiratory,ICD-10
J631,Bauxite fibrosis (of lung),Respiratory,ICD-10
J633,Graphite fibrosis (of lung),Respiratory,ICD-10
J634,Siderosis,Respiratory,ICD-10
J635,Stannosis,Respiratory,ICD-10
J660,Byssinosis,Respiratory,ICD-10
J661,Flax-dresser disease,Respiratory,ICD-10
J662,Cannabinosis,Respiratory,ICD-10
J668,Airway disease due to other specific organic dusts,Respiratory,ICD-10
J670,Farmer lung,Respiratory,ICD-10
J671,Bagassosis,Respiratory,ICD-10
J678,Hypersensitivity pneumonitis due to other organic dusts,Respiratory,ICD-10
J684,"Chronic respiratory conditions due to chemicals, gases, fumes and vapours",Respiratory,ICD-10
J688,"Other respiratory conditions due to chemicals, gases, fumes and vapours",Respiratory,ICD-10
J698,Pneumonitis due to other solids and liquids,Respiratory,ICD-10
J701,Chronic and other pulmonary manifestations due to radiation,Respiratory,ICD-10
J703,Chronic drug-induced interstitial lung disorders,Respiratory,ICD-10
J721,Transplantation of spleen,Transplant,OPCS-4
J840,Alveolar and parietoalveolar conditions,Respiratory,ICD-10
J983,Compensatory emphysema,Respiratory,ICD-10
J991,Respiratory disorders in other diffuse connective tissue disorders,Respiratory,ICD-10
K01,Transplantation of heart and lung,Transplant,OPCS-4
K02,Other transplantation of heart,Transplant,OPCS-4
L412,Lymphomatoid papulosis,Haematological Cancers,ICD-10
M012,Allotransplantation of kidney from live donor,Transplant,OPCS-4
M013,Allotransplantation of kidney from cadaver NEC,Transplant,OPCS-4
M014,Allotransplantation of kidney from cadaver heart beating,Transplant,OPCS-4
M015,Allotransplantation of kidney from cadaver heart non-beating,Transplant,OPCS-4
M018,Other specified transplantation of kidney,Transplant,OPCS-4
M019,Unspecified transplantation of kidney,Transplant,OPCS-4
M312,Lethal midline granuloma,Cancer undergoing active chemo/radiotherapy,ICD-10
M313,Wegener granulomatosis,Respiratory,ICD-10
P250,Interstitial emphysema originating in the perinatal period,Respiratory,ICD-10
P615,Transient neonatal neutropenia,Haematological Cancers,ICD-10
Q200,Common arterial trunk,Congenital Heart,ICD-10
Q203,Discordant ventriculoarterial connection,Congenital Heart,ICD-10
Q204,Double inlet ventricle,Congenital Heart,ICD-10
Q205,Discordant atrioventricular connection,Congenital Heart,ICD-10
Q208,Other congenital malformations of cardiac chambers and connections,Congenital Heart,ICD-10
Q211,Atrial septal defect,Congenital Heart,ICD-10
Q212,Atrioventricular septal defect,Congenital Heart,ICD-10
Q223,Other congenital malformations of pulmonary valve,Congenital Heart,ICD-10
Q231,Congenital insufficiency of aortic valve,Congenital Heart,ICD-10
Q238,Other congenital malformations of aortic and mitral valves,Congenital Heart,ICD-10
Q245,Malformation of coronary vessels,Congenital Heart,ICD-10
Q248,Other specified congenital malformations of heart,Congenital Heart,ICD-10
Q254,Other congenital malformations of aorta,Congenital Heart,ICD-10
Q268,Other congenital malformations of great veins,Congenital Heart,ICD-10
Q288,Other specified congenital malformations of circulatory system,Congenital Heart,ICD-10
Q334,Congenital bronchiectasis,Respiratory,ICD-10
Q851,Tuberous sclerosis,"Rare genetic, metabolic and autoimmune diseases",ICD-10
Q859,"Phakomatosis, unspecified","Rare genetic, metabolic and autoimmune diseases",ICD-10
Q878,"Other specified congenital malformation syndromes, not elsewhere classified",Congenital Heart,ICD-10
Q878,"Other specified congenital malformation syndromes, not elsewhere classified","Rare genetic, metabolic and autoimmune diseases",ICD-10
Q893,Situs inversus,Congenital Heart,ICD-10
Q898,Other specified congenital malformations,Congenital Heart,ICD-10
T508,Other specified transplantation of fascia,Transplant,OPCS-4
T509,Unspecified transplantation of fascia,Transplant,OPCS-4
T768,Other specified transplantation of muscle,Transplant,OPCS-4
T769,Unspecified transplantation of muscle,Transplant,OPCS-4
T860,Bone-marrow transplant rejection,Transplant,ICD-10
T861,Kidney transplant failure and rejection,Transplant,ICD-10
T862,Heart transplant failure and rejection,Transplant,ICD-10
T863,Heart-lung transplant failure and rejection,Transplant,ICD-10
T864,Liver transplant failure and rejection,Transplant,ICD-10
T8681,Failure and rejection of other transplanted organs and tissues,Transplant,ICD-10
T8682,Failure and rejection of other transplanted organs and tissues,Transplant,ICD-10
T8688,Failure and rejection of other transplanted organs and tissues,Transplant,ICD-10
T869,Failure and rejection of unspecified transplanted organ and tissue,Transplant,ICD-10
W342,Allograft of bone marrow NEC,Transplant,OPCS-4
W343,Allograft of bone marrow from sibling donor,Transplant,OPCS-4
W344,Allograft of bone marrow from matched unrelated donor,Transplant,OPCS-4
W345,Allograft of bone marrow from haploidentical donor,Transplant,OPCS-4
W346,Allograft of bone marrow from unmatched unrelated donor,Transplant,OPCS-4
W348,Other specified graft of bone marrow,Transplant,OPCS-4
W349,Unspecified graft of bone marrow,Transplant,OPCS-4
X336,Allogeneic peripheral,Transplant,OPCS-4
X65,Radiotherapy delivery,Cancer undergoing active chemo/radiotherapy,OPCS-4
X70-X74,Procurement and Delivery of Chemotherapy,Cancer undergoing active chemo/radiotherapy,OPCS-4
Z510,Radiotherapy session,Cancer undergoing active chemo/radiotherapy,ICD-10
Z511,Chemotherapy session for neoplasm,Cancer undergoing active chemo/radiotherapy,ICD-10
Z940,Transplanted organ and tissue status,Transplant,ICD-10
Z941,Transplanted organ and tissue status,Transplant,ICD-10
Z942,Transplanted organ and tissue status,Transplant,ICD-10
Z943,Transplanted organ and tissue status,Transplant,ICD-10
Z944,Transplanted organ and tissue status,Transplant,ICD-10
Z945,Transplanted organ and tissue status,Transplant,ICD-10
Z946,Transplanted organ and tissue status,Transplant,ICD-10
Z947,Transplanted organ and tissue status,Transplant,ICD-10
Z948,Transplanted organ and tissue status,Transplant,ICD-10
Z949,Transplanted organ and tissue status,Transplant,ICD-10